Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARAV Aravive Inc

0.00 (0.00%)
Apr 18 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.042
Ask Price 0.0428
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Aravive Inc ARAV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0401 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0401 0.0401
Trades Volume Avg Volume 52 Week Range
0 0 - 0.04 - 1.98
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0401 USD

Aravive Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.95M - - - -3.87
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aravive News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ARAV Message Board. Create One! See More Posts on ARAV Message Board See More Message Board Posts

Historical ARAV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.04350.0460.04010.04013,925,638-0.0034-7.82%
6 Months0.16480.2490.040.13967384,441,161-0.1247-75.67%
1 Year1.781.980.040.20345054,664,844-1.74-97.75%
3 Years5.186.940.040.54270591,478,988-5.14-99.23%
5 Years6.2329.600.041.23934,953-6.19-99.36%

Aravive Description

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Aravive's lead candidate is batiraxcept, which is is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway.

Your Recent History

Delayed Upgrade Clock